Literature DB >> 1587593

Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients.

L M Loomes1, B W Senior, M A Kerr.   

Abstract

The proteinases secreted by pathogenic strains of Proteus mirabilis, P. vulgaris biotype 2, P. vulgaris biotype 3, and P. penneri were purified with almost 100% recovery by affinity chromatography on phenyl-Sepharose followed by anion-exchange chromatography. The proteinase purified from the urinary tract pathogen P. mirabilis, which we had previously shown to degrade immunoglobulins A and G, appeared as a composite of a single band and a double band (53 and 50 kDa, respectively) on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The other Proteus proteinases had similar patterns but slightly different mobilities. In each case all proteinase activity in culture supernatants was demonstrated by gelatin-sodium dodecyl sulfate-polyacrylamide gel electrophoresis to be associated with only the triple-band complex; all three bands were proteolytically active. The P. mirabilis proteinase was resistant to inhibitors of both serine and thiol proteinases but strongly inhibited by metal chelators, although it was not affected by phosphoramidon, an inhibitor of the thermolysin group of bacterial metalloproteinases. Active proteinase was detected in urine samples from P. mirabilis-infected patients; this is consistent with our detection of immunoglobulin A fragments of a size suggestive of P. mirabilis proteinase activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587593      PMCID: PMC257153          DOI: 10.1128/iai.60.6.2267-2273.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  OBSERVATIONS ON A PROTEASE FROM PROTEUS MIRABILIS.

Authors:  S E HAMPSON; G L MILLS; T SPENCER
Journal:  Biochim Biophys Acta       Date:  1963-07-09

2.  The specificity of the human neutrophil IgA receptor (Fc alpha R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2.

Authors:  W W Stewart; M A Kerr
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  The specificity of the IgA receptor purified from human neutrophils.

Authors:  R L Mazengera; M A Kerr
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

4.  A survey of IgA protease production among clinical isolates of Proteeae.

Authors:  B W Senior; M Albrechtsen; M A Kerr
Journal:  J Med Microbiol       Date:  1988-01       Impact factor: 2.472

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens.

Authors:  A Molla; T Kagimoto; H Maeda
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

7.  Proteus mirabilis strains of diverse type have IgA protease activity.

Authors:  B W Senior; M Albrechtsen; M A Kerr
Journal:  J Med Microbiol       Date:  1987-09       Impact factor: 2.472

8.  The production and activity in vivo of Proteus mirabilis IgA protease in infections of the urinary tract.

Authors:  B W Senior; L M Loomes; M A Kerr
Journal:  J Med Microbiol       Date:  1991-10       Impact factor: 2.472

9.  Characterization of the IgA receptor from human polymorphonuclear leucocytes.

Authors:  M Albrechtsen; G R Yeaman; M A Kerr
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

10.  The anticomplementary effect of kidney tissue; its association with ammonia production.

Authors:  P B BEESON; D ROWLEY
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

View more
  10 in total

1.  Identification and characterization of a metalloprotease activity from Helicobacter pylori.

Authors:  H J Windle; D Kelleher
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 2.  Pathogenesis of Proteus mirabilis Infection.

Authors:  Chelsie E Armbruster; Harry L T Mobley; Melanie M Pearson
Journal:  EcoSal Plus       Date:  2018-02

Review 3.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

4.  A comparison of the binding of secretory component to immunoglobulin A (IgA) in human colostral S-IgA1 and S-IgA2.

Authors:  Adel Almogren; Bernard W Senior; Michael A Kerr
Journal:  Immunology       Date:  2006-11-29       Impact factor: 7.397

5.  Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition.

Authors:  A N Neely; R G Miller; I A Holder
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Molecular analysis of a metalloprotease from Proteus mirabilis.

Authors:  C Wassif; D Cheek; R Belas
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

7.  Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides.

Authors:  Robert Belas; Jim Manos; Rooge Suvanasuthi
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 8.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Structural and functional consequences of cleavage of human secretory and human serum immunoglobulin A1 by proteinases from Proteus mirabilis and Neisseria meningitidis.

Authors:  Adel Almogren; Bernard W Senior; Lesley M Loomes; Michael A Kerr
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Giant magnetoresistive biosensors for real-time quantitative detection of protease activity.

Authors:  Sandeep Adem; Sonal Jain; Michael Sveiven; Xiahan Zhou; Anthony J O'Donoghue; Drew A Hall
Journal:  Sci Rep       Date:  2020-05-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.